Search

Author/Creator Pacaud, L.

1. 5LBA Everolimus in advanced nonfunctional neuroendocrine tumors (NET) of lung or gastrointestinal (GI) origin: Efficacy and safety results from the placebo-controlled, double-blind, multicenter, Phase 3 RADIANT-4 study. (September 2015)

Authors:
Yao, J.; Fazio, N.; Singh, S.; Buzzoni, R.; Carnaghi, C.; Wolin, E.; Tomasek, J.; Raderer, M.; Lahner, H.; Voi, M.; Pacaud, L.; Lincy, J.; Sachs, C.; Valle, J.; Delle Fave, G.; Van Cutsem, E.; Tesselaar, M.E.T.; Shimada, Y.; Oh, D.Y.; Strosberg, J.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S709
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. BIANCA: A PHASE 2 STUDY OF THE SAFETY AND EFFICACY OF TISAGENLECLEUCEL IN PEDIATRIC PATIENTS WITH RELAPSED/REFRACTORY MATURE B‐CELL NON‐HODGKIN LYMPHOMA. (12th June 2019)

Authors:
Minard‐Colin, V.; Burkhardt, B.; Maude, S.; Phillips, C.; Diaz de Heredia Rubio, C.; Laetsch, T.W.; Curran, K.; Newsome, S.; Murray, N.; Pacaud, L.; Buechner, J.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
558
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. CORRELATIVE ANALYSES OF CYTOKINE RELEASE SYNDROME AND NEUROLOGICAL EVENTS IN TISAGENLECLEUCEL‐TREATED RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA PATIENTS. (12th June 2019)

Authors:
Bachanova, V.; Westin, J.; Tam, C.; Borchmann, P.; Jaeger, U.; McGuirk, J.; Holte, H.; Waller, E.; Jaglowski, S.; Bishop, M.; Andreadis, C.; Foley, S.R.; Fleury, I.; Teshima, T.; Mielke, S.; Salles, G.; Ho, P.J.; Izutsu, K.; Maziarz, R.; Van Besien, K.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
308
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. ELARA: A PHASE 2 TRIAL INVESTIGATING THE EFFICACY AND SAFETY OF TISAGENLECLEUCEL IN ADULT PATIENTS WITH REFRACTORY/RELAPSED FOLLICULAR LYMPHOMA. (12th June 2019)

Authors:
Dickinson, M.; Popplewell, L.; Kolstad, A.; Ho, P.J.; Teshima, T.; Dreyling, M.; Schuster, S.; Thieblemont, C.; Ghosh, M.; Riedell, P.; Yateman, N.; Lehnhoff, K.; Lawniczek, T.; Pacaud, L.; Fowler, N.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
559
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. GLOBAL PIVOTAL PHASE 2 TRIAL OF THE CD19‐TARGETED THERAPY CTL019 IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL)—AN INTERIM ANALYSIS. (June 2017)

Authors:
Schuster, S.J.; Bishop, M.R.; Tam, C.; Waller, E.K.; Borchmann, P.; Mcguirk, J.; Jäger, U.; Jaglowski, S.; Andreadis, C.; Westin, J.; Fleury, I.; Bachanova, V.; Foley, S.R.; Ho, P.J.; Mielke, S.; Holte, H.; Anak, O.; Pacaud, L.; Awasthi, R.; Tai, F.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
27
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. INTRAVENOUS IMMUNOGLOBULIN THERAPY USE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA TREATED WITH TISAGENLECLEUCEL IN THE JULIET TRIAL. (12th June 2019)

Authors:
Jaeger, U.; Tam, C.; Borchmann, P.; McGuirk, J.; Holte, H.; Waller, E.; Jaglowski, S.; Andreadis, C.; Foley, S.R.; Fleury, I.; Westin, J.; Teshima, T.; Mielke, S.; Salles, G.; Ho, P.J.; Izutsu, K.; Schuster, S.; Bachanova, V.; Maziarz, R.; Van Besien, K.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
505
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. P899: REAL-WORLD ASSESSMENT OF TREATMENT PATTERNS AND OUTCOMES IN PATIENTS WITH LENALIDOMIDE-REFRACTORY RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM THE OPTUM DATABASE. (23rd June 2022)

Authors:
Dhakal, B.; Einsele, H.; Potluri, R.; Schecter, J.; Deraedt, W.; Lendvai, N.; Slaughter, A.; Lonardi, C.; Nair, S.; He, J.; Joseph, N.; Cost, P.; Valluri, S.; Yalniz, F.; Pacaud, L.; Yong, K.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
790
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. P959: CILTACABTAGENE AUTOLEUCEL IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA AFTER 1-3 PRIOR LINES OF THERAPY: CARTITUDE-2 BIOLOGICAL CORRELATIVE ANALYSES AND UPDATED CLINICAL DATA. (23rd June 2022)

Authors:
Hillengass, J.; Cohen, A. D.; Delforge, M.; Einsele, H.; Goldschmidt, H.; Weisel, K.; Raab, M.-S.; Scheid, C.; Schecter, J. M.; De Braganca, K. C.; Varsos, H.; Yeh, T.-M.; Mistry, P.; Roccia, T.; Corsale, C.; Akram, M.; Pacaud, L.; Nesheiwat, T.; Agha, M.; Cohen, Y. C.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
849
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. P961: CILTACABTAGENE AUTOLEUCEL, A BCMA-DIRECTED CAR-T CELL THERAPY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: 2-YEAR POST LPI RESULTS FROM THE PHASE 1B/2 CARTITUDE-1 STUDY. (23rd June 2022)

Authors:
Lin, Y.; Martin, T.; Berdeja, J. G.; Jakubowiak, A.; Agha, M.; Cohen, A. D.; Deol, A.; Htut, M.; Lesokhin, A.; Munshi, N. C.; O'Donnell, E.; Jackson, C. C.; Yeh, T.-M.; Banerjee, A.; Zudaire, E.; Madduri, D.; Zhou, C.; Pacaud, L.; Usmani, S. Z.; Jagannath, S.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
851
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. P971: ADJUSTED COMPARISON OF PATIENT REPORTED OUTCOMES FROM CARTITUDE-1 AND LOCOMMOTION COMPARING CILTACABTAGENE AUTOLEUCEL VERSUS REAL WORLD CLINICAL PRACTICE IN TRIPLE-CLASS EXPOSED MULTIPLE MYELOMA. (23rd June 2022)

Authors:
Weisel, K.; Mateos, M.-V.; Vincent, L.; Martin, T.; Berdeja, J. G.; Jakubowiak, A.; Jagannath, S.; Lin, Y.; Thilakarathne, P.; Ghilotti, F.; Diels, J.; Haefliger, B.; Hague, C.; Gonzalez, A.; Schecter, J. M.; Gries, K. S.; Strulev, V.; Nesheiwat, T.; Pacaud, L.; Einsele, H.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
861
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗